Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 188

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Sirtuin 1 Is Upregulated in a Subset of Hepatocellular Carcinomas where It Is Essential for Telomere Maintenance and Tumor Cell Growth

Open access
Chen, Juan, Zhang, Bin, Wong, Nathalie, Lo, Anthony W.I., To, Ka-Fai, Chan, Anthony W.H., Ng, Margaret H.L., Ho, Cecilia Y.S., Cheng, Suk-Hang, Lai, Paul B.S., Yu, Jun, Ng, Ho-Keung, Ling, Ming-Tat, Huang, Ai-Long, Cai, Xue-Fei, Ko, Ben C.B.·2011·Cancer Research

Published version of a preprint

Abstract

Hepatocellular carcinoma (HCC) is a highly malignant tumor with a poor prognosis. Treatment of HCC is complicated by the fact that the disease is often diagnosed at an advanced stage when it is no longer amenable to curative surgery, and current systemic chemotherapeutics are mostly inefficacious. Sirtuin 1 (SIRT1) is a class III histone deacetylase that is implicated in gene regulations and stress resistance. In this study, we found that SIRT1 is essential for the tumorigenesis of HCC. We showed that although SIRT1 was expressed at very low levels in normal livers, it was overexpressed in HCC cell lines and in a subset of HCC. Tissue microarray analysis of HCC and adjacent nontumoral liver tissues revealed a positive correlation between the expression levels of SIRT1 and advancement in tumor grades. Downregulation of SIRT1 consistently suppressed the proliferation of HCC cells via the induction of cellular senescence or apoptosis. SIRT1 silencing also caused telomere dysfunction–induced foci and nuclear abnormality that were clearly associated with reduced expressions of telomerase reverse transcriptase (TERT), and PTOP, which is a member of the shelterin complex. Ectopic expression of either TERT or PTOP in SIRT1-depleted cells significantly restored cell proliferation. There was also a positive correlation between the level of induction of SIRT1 and PTOP in human HCC. Finally, SIRT1-silencing sensitized HCC cells to doxorubicin treatment. Together, our findings reveal a novel function for SIRT1 in telomere maintenance of HCC, and they rationalize the clinical exploration of SIRT1 inhibitors for HCC therapy. Cancer Res; 71(12); 4138–49. ©2011 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-10-4274

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 38

  1. El-Serag, 2007, Hepatocellular carcinoma: epidemiology and molecular carcinogenesis, Gastroenterology, 132, 2557, 10.1053/j.gastro.2007.04.061 · DOI · Paper page
  2. But, 2008, Natural history of hepatitis-related hepatocellular carcinoma, World J Gastroenterol, 14, 1652, 10.3748/wjg.14.1652 · DOI · Paper page
  3. Greten, 2005, Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients, Br J Cancer, 92, 1862, 10.1038/sj.bjc.6602590 · DOI · Paper page
  4. Yeo, 2005, A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma, J Natl Cancer Inst, 97, 1532, 10.1093/jnci/dji315 · DOI · Paper page
  5. Blander, 2004, The Sir2 family of protein deacetylases, Annu Rev Biochem, 73, 417, 10.1146/annurev.biochem.73.011303.073651 · DOI · Paper page
  6. Michan, 2007, Sirtuins in mammals: insights into their biological function, Biochem J, 404, 1, 10.1042/BJ20070140 · DOI · Paper page
  7. Haigis, 2010, Mammalian sirtuins: biological insights and disease relevance, Annu Rev Pathol, 5, 253, 10.1146/annurev.pathol.4.110807.092250 · DOI · Paper page
  8. Oberdoerffer, 2008, SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging, Cell, 135, 907, 10.1016/j.cell.2008.10.025 · DOI · Paper page
  9. Palacios, 2010, SIRT1 contributes to telomere maintenance and augments global homologous recombination, J Cell Biol, 191, 1299, 10.1083/jcb.201005160 · DOI · Paper page
  10. El Ramy, 2009, Functional interplay between Parp-1 and SirT1 in genome integrity and chromatin-based processes, Cell Mol Life Sci, 66, 3219, 10.1007/s00018-009-0105-4 · DOI
  11. Yuan, 2009, Histone H3-K56 acetylation is important for genomic stability in mammals, Cell Cycle, 8, 1747, 10.4161/cc.8.11.8620 · DOI · Paper page
  12. Wong, 2009, TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance, Int J Cancer, 124, 644, 10.1002/ijc.23968 · DOI · Paper page
  13. Tong, 2009, Inducible nucleosome depletion at OREBP-binding-sites by hypertonic stress, PLoS One, 4, e8435, 10.1371/journal.pone.0008435 · DOI
  14. Wong, 2005, Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo, Clin Cancer Res, 11, 6002, 10.1158/1078-0432.CCR-05-0209 · DOI
  15. Cheng, 2010, Reduced CRYL1 expression in hepatocellular carcinoma confers cell growth advantages and correlates with adverse patient prognosis, J Pathol, 220, 348, 10.1002/path.2644 · doi:10.1002/path.2644
  16. Law, 2010, Alisol B, a novel inhibitor of the sarcoplasmic/endoplasmic reticulum Ca(2+) ATPase pump, induces autophagy, endoplasmic reticulum stress, and apoptosis, Mol Cancer Ther, 9, 718, 10.1158/1535-7163.MCT-09-0700 · DOI
  17. Ota, 2006, Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells, Oncogene, 25, 176, 10.1038/sj.onc.1209049 · DOI · Paper page
  18. Pedeux, 2005, ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation, Mol Cell Biol, 25, 6639, 10.1128/MCB.25.15.6639-6648.2005 · DOI
  19. Palm, 2008, How shelterin protects mammalian telomeres, Annu Rev Genet, 42, 301, 10.1146/annurev.genet.41.110306.130350 · DOI · Paper page
  20. Kibe, 2010, Telomere protection by TPP1 is mediated by POT1a and POT1b, Mol Cell Biol, 30, 1059, 10.1128/MCB.01498-09 · DOI
  21. Xin, 2007, TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase, Nature, 445, 559, 10.1038/nature05469 · DOI · Paper page
  22. Wang, 2008, Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice, Cancer Cell, 14, 312, 10.1016/j.ccr.2008.09.001 · DOI · Paper page
  23. Bradbury, 2005, Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors, Leukemia, 19, 1751, 10.1038/sj.leu.2403910 · DOI · Paper page
  24. Huffman, 2007, SIRT1 is significantly elevated in mouse and human prostate cancer, Cancer Res, 67, 6612, 10.1158/0008-5472.CAN-07-0085 · DOI · Paper page
  25. Hida, 2007, Strong expression of a longevity-related protein, SIRT1, in Bowen's disease, Arch Dermatol Res, 299, 103, 10.1007/s00403-006-0725-6 · DOI · Paper page
  26. Cha, 2009, Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma, Clin Cancer Res, 15, 4453, 10.1158/1078-0432.CCR-08-3329 · DOI · Paper page
  27. Stünkel, 2007, Function of the SIRT1 protein deacetylase in cancer, Biotechnol J, 2, 1360, 10.1002/biot.200700087 · DOI · Paper page
  28. Ford, 2005, Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival, Cancer Res, 65, 10457, 10.1158/0008-5472.CAN-05-1923 · DOI · Paper page
  29. Heltweg, 2006, Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes, Cancer Res, 66, 4368, 10.1158/0008-5472.CAN-05-3617 · DOI · Paper page
  30. Olovnikov, 1973, A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon, J Theor Biol, 41, 181, 10.1016/0022-5193(73)90198-7 · doi:10.1016/0022-5193(73)90198-7
  31. Ozturk, 2008, Senescence and immortality in hepatocellular carcinoma, Cancer Lett
  32. Stewart, 2006, Telomeres: cancer to human aging, Annu Rev Cell Dev Biol, 22, 531, 10.1146/annurev.cellbio.22.010305.104518 · DOI · Paper page
  33. Ahmed, 2008, Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress, J Cell Sci, 121, 1046, 10.1242/jcs.019372 · DOI · Paper page
  34. Poncet, 2008, Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia, Blood, 111, 2388, 10.1182/blood-2007-09-111245 · DOI
  35. Cookson, 2009, The levels of telomere-binding proteins in human tumours and therapeutic implications, Eur J Cancer, 45, 536, 10.1016/j.ejca.2008.11.014 · DOI
  36. Veldman, 2004, Loss of hPot1 function leads to telomere instability and a cut-like phenotype, Curr Biol, 14, 2264, 10.1016/j.cub.2004.12.031 · DOI
  37. Barrientos, 2008, Distinct functions of POT1 at telomeres, Mol Cell Biol, 28, 5251, 10.1128/MCB.00048-08 · DOI
  38. Liu, 2009, The critical role of the class III histone deacetylase SIRT1 in cancer, Cancer Res, 69, 1702, 10.1158/0008-5472.CAN-08-3365 · DOI · Paper page

Cited by

See all 188

Metadata

Authors
Chen, J., Zhang, B., Wong, N., Lo, A. W. I., To, K.-F., Chan, A. W. H., Ng, M. H. L., Ho, C. Y. S., Cheng, S.-H., Lai, P. B. S., Yu, J., Ng, H.-K., Ling, M.-T., Huang, A.-L., Cai, X.-F., & Ko, B. C. B.
Venue
Cancer Research
Published
2011-06-14
Volume
71
Issue
12
Pages
4138-4149
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2170096414
Cited by
188
References
11
FWCI
6.78
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sirtuin 1 Is Upregulated in a Subset of Hepatocellular Carcinomas where It Is Essential for Telomere Maintenance and Tumor Cell Growth. https://app.cochat.ai/papers/10.1158/0008-5472.can-10-4274
The paper
Chen, J., Zhang, B., Wong, N., Lo, A. W. I., To, K.-F., Chan, A. W. H., Ng, M. H. L., Ho, C. Y. S., Cheng, S.-H., Lai, P. B. S., Yu, J., Ng, H.-K., Ling, M.-T., Huang, A.-L., Cai, X.-F., & Ko, B. C. B. (2011). Sirtuin 1 Is Upregulated in a Subset of Hepatocellular Carcinomas where It Is Essential for Telomere Maintenance and Tumor Cell Growth. Cancer Research. https://doi.org/10.1158/0008-5472.can-10-4274

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.